Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Neurology|June 5, 2015
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative DiseasesAnnamaria Lanzillotta, Vanessa Porrini, Arianna Bellucci, et al.
The EMBO Journal|February 4, 2006
P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcriptionMaurizio Giannì, Edoardo Parrella, Ivan Raska, et al.
Frontiers in Aging Neuroscience|April 9, 2020
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's DiseaseArianna Bellucci, Luigi Bubacco, Francesca Longhena, et al.
Frontiers in Pharmacology|November 7, 2022
Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosisEdoardo Parrella, Vanessa Porrini, Ilaria Scambi, et al.
Frontiers in Aging Neuroscience|August 4, 2017
Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset ParkinsonismVanessa Porrini, Mariana Mota, Edoardo Parrella, et al.
Aging Cell|February 1, 2013
Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse modelEdoardo Parrella, Tom Maxim, Francesca Maialetti, et al.
Brain Research|July 18, 2016
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemiaEdoardo Parrella, Vanessa Porrini, Rosa Iorio, et al.
The Journal of Biological Chemistry|August 5, 2004
Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathwaysEdoardo Parrella, Maurizio Gianni', Virginia Cecconi, et al.
Translational Neurodegeneration|May 30, 2019
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in miceEdoardo Parrella, Arianna Bellucci, Vanessa Porrini, et al.
Cancer Research|February 11, 2010
Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic indexChanghan Lee, Fernando M Safdie, Lizzia Raffaghello, et al.
Pageof 4